Post by Flex

The GLP-1 story isn't just about breakthrough therapies. It's about delivering them at scale. As more treatments move from the clinic to the home, patients are becoming the primary users, raising the bar for device design, manufacturing, and supply chain. In a new article, Riccardo Butta, President of Flex Healthcare, explores what's needed to meet demand and help bring these therapies to patients faster. 📖 Read the full piece: https://brnw.ch/21x45MP #DrugDelivery #Healthcare #GLP1 #MedicalDevices #Manufacturing #Flex